(Transnasal Humidified Rapid-Insufflation Ventilatory Exchange)

 

Optiflow THRIVE™ provides effective oxygenation and extends safe apnoea time during anaesthesia. 1,2,3,4


 

 

If you have an enquiry about our products, please provide the following information so a Fisher & Paykel Healthcare representative can contact you. For further details on how this information will be used, see below or go to our privacy statement.

* Required Information

     
  
 
Enter security code
 Security code
     
By submitting this form, you consent to Fisher & Paykel Healthcare storing your personal information to contact you about your enquiry. Your information will be collected and stored securely by Fisher & Paykel Healthcare Limited based in New Zealand and may be shared with the wider Fisher & Paykel Healthcare group as necessary to support your enquiry. We will not share, disclose or sell your information to third parties for marketing purposes. For full details on how we use and manage your personal information, how long we may retain this information for sales or marketing purposes, your rights to access, correct or delete your personal information, and how to contact us about your personal information, please see our privacy statement.
     
   
 
 

Sign up to receive email updates on new clinical publications and registered clinical trials on Optiflow THRIVE

Woman wearing Optiflow Nasal High Flow


Optiflow Nasal High Flow mechanisms of action

For safety and performance information, please refer to the user instructions provided with our products. Optiflow and Optiflow THRIVE are trademarks of Fisher and Paykel Healthcare Limited.
For patent information, see www.fphcare.com/ip
 
1. Wong DT, Dallaire A, Singh KP,  et al. High-flow nasal oxygen improves safe apnea time in morbidly obese patients undergoing general anesthesia: a randomized controlled trial. Anesthesia & Analgesia. 2019 Oct 1;129(4):1130-6.

2. Lodenius Å, Piehl J, Östlund A, et al. Transnasal humidified rapid‐insufflation ventilatory exchange (THRIVE) vs. facemask breathing pre‐oxygenation for rapid sequence induction in adults: a prospective randomised non‐blinded clinical trial. Anaesthesia. 2018 May;73(5):564-71.

3. Gustafsson IM, Lodenius Å, Tunelli J, et al. Apnoeic oxygenation in adults under general anaesthesia using Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) – a physiological study. British Journal of Anaesthesia. 2017 Apr 1;118(4):610-17.

4. Patel A, Nouraei SR. Transnasal Humidified Rapid‐Insufflation Ventilatory Exchange (THRIVE): a physiological method of increasing apnoea time in patients with difficult airways. Anaesthesia. 2015 Mar;70(3):323-9.